Lumios
ETH spin-off
Zurich, SwitzerlandAbout
Lumios is developing 3D-printed nerve grafts designed to regenerate damaged peripheral nerves and restore functional recovery. Our technology combines advanced biomaterial with high-resolution laser-based printing to create grafts that mimic the native nerve architecture and guide regenerating axons with unprecedented precision.
Unlike traditional autografts, which are limited by donor-site morbidity and tissue availability, our engineered grafts offer a scalable, consistent, and personalized alternative. Each graft can be customized to the patient’s anatomy, injury length, and regenerative needs, enabling faster and more reliable nerve repair.
Lumios aims to provide surgeons with a transformative solution to improve outcomes in nerve reconstruction and reduce long-term disability for millions of patients worldwide.
Covered funding stages of your organization / Spin-off Funding Stage
Industry Sector your organization invests in / Industry Sector of your Spin-off
Target Markets of your organization / Expansion or target markets of your spin-off
Representatives
Lumios, ETH Pioneer fellow
Lumios